MAT Waiver Training Initiative

MAT Waiver Training Initiative

PAEA is partnering with the American Academy of Addiction Psychiatry and a coalition of national professional organizations in a grant funded by SAMHSA called State Targeted Response-Technical Assistance (STR-TA). PAEA as a partner organization will focus on assisting PA programs with incorporating medication-assisted treatment (MAT) waiver training into their curricula. PAEA’s vision is that all PA program graduates and faculty will be waiver eligible.

 

 

What is MAT?

MAT is the use of medications to treat persons with opiate use disorder. The three medications approved by the FDA for MAT are methadone, buprenorphine, and naltrexone.

Funding for this grant from the Substance Abuse and Mental Health Services Administration will help us assist programs with incorporating MAT training into PA programs’ curricula.


NIDA. (2016, November 1). Effective Treatments for Opioid Addiction. Retrieved on June 25, 2018

  • PAs can apply for the DEA X-waiver to prescribe buprenorphine for MAT of opioid use disorder following completion of 24 hours of training by an approved organization.
  • MAT waiver training is provided by these DATA 2000 approved sponsors:
    • American Academy of Addiction Psychiatry (AAAP)
    • American Society of Addiction Medicine (ASAM)
    • American Osteopathic Academy of Addiction Medicine (AOAAM)
    • American Psychiatric Association (APA)
  • The American Academy of Physician Assistants approved MAT waiver training for 24 hours of category I CME credits.

NPI as a Unique Identifier

Member programs will also be encouraged to sign up students for a unique identifier (e.g., National Provider Identification) to facilitate short- and long-term outcomes measurement of the MAT waiver training project. Download this document for more information. Watch the tutorial on the right.

 

 

Resources on Training

Click on each category header to view relevant links.

Get in Touch

Contact John Lopes, MAT Initiative Project director at jlopes@paeaonline.org or 703-667-4322.

Funding for this initiative was made possible by grant no. 1H79TI080816-01 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.